Flagship Pioneering, LLC Long-Term Concentrated

CIK: 0001400240 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value ($000): $3,132,284 (100.0% shares, 0.0% debt)

Holdings (12)

MRNA Moderna Inc 73.9%

Value ($000) $2,314,717 Shares 12,886,743 Est. Cost $16.43 Unrealized +895.0%

— Omega Therapeutics Inc 9.4%

Value ($000) $293,473 Shares 25,902,269 Est. Cost $18.85 Unrealized —

SANA Sana Biotechnology Inc 4.3%

Value ($000) $135,244 Shares 34,239,018 Est. Cost $32.56 Unrealized -85.0%

— Seres Therapeutics Inc 4.1%

Value ($000) $129,455 Shares 23,117,045 Est. Cost $7.75 Unrealized —

— Evelo Biosciences Inc 2.6%

Value ($000) $81,188 Shares 50,427,328 Est. Cost $5.89 Unrealized —

FHTX Foghorn Therapeutics Inc 2.6%

Value ($000) $80,861 Shares 12,674,120 Est. Cost $19.16 Unrealized -60.6%

DNLI Denali Therapeutics Inc 2.3%

Value ($000) $72,861 Shares 2,619,968 Est. Cost $17.97 Unrealized +65.6%

— Axcella Health Inc 0.3%

Value ($000) $9,360 Shares 29,251,545 Est. Cost $4.17 Unrealized —

— Rubius Therapeutics Inc 0.2%

Value ($000) $6,546 Shares 38,506,526 Est. Cost $24.00 Unrealized —

— Sigilon Therapeutics Inc 0.1%

Value ($000) $3,630 Shares 10,370,369 Est. Cost $48.03 Unrealized —

SYRS Syros Pharmaceuticals Inc 0.1%

Value ($000) $3,568 Shares 993,848 Est. Cost $8.12 Unrealized -46.6%

— Codiak Biosciences Inc 0.0%

Value ($000) $1,381 Shares 3,540,636 Est. Cost $23.99 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MRNA	Moderna Inc	12,886,743	$2,314,717	73.9%	$16.43	+895.0%	COM	60770K107
—	Omega Therapeutics Inc	25,902,269	$293,473	9.4%	$18.85	—	COM	68217N105
SANA	Sana Biotechnology Inc	34,239,018	$135,244	4.3%	$32.56	-85.0%	COM	799566104
—	Seres Therapeutics Inc	23,117,045	$129,455	4.1%	$7.75	—	COM	81750R102
—	Evelo Biosciences Inc	50,427,328	$81,188	2.6%	$5.89	—	COM	299734103
FHTX	Foghorn Therapeutics Inc	12,674,120	$80,861	2.6%	$19.16	-60.6%	COM	344174107
DNLI	Denali Therapeutics Inc	2,619,968	$72,861	2.3%	$17.97	+65.6%	COM	24823R105
—	Axcella Health Inc	29,251,545	$9,360	0.3%	$4.17	—	COM	05454B105
—	Rubius Therapeutics Inc	38,506,526	$6,546	0.2%	$24.00	—	COM	78116T103
—	Sigilon Therapeutics Inc	10,370,369	$3,630	0.1%	$48.03	—	COM	82657L107
SYRS	Syros Pharmaceuticals Inc	993,848	$3,568	0.1%	$8.12	-46.6%	COM	87184Q206
—	Codiak Biosciences Inc	3,540,636	$1,381	0.0%	$23.99	—	COM	192010106